Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Bullfrog AI Holdings, Inc. develops and applies proprietary artificial intelligence and machine learning technology, bfLEAP™, to enhance drug development by analyzing complex preclinical and clinical data. The company focuses on rescuing and advancing therapeutics, particularly in oncology and rare diseases, through data-driven patient stratification and trial optimization. Its business model includes licensing drug rights, collaborative partnerships, and fee-for-service analytics targeting biopharmaceutical companies and research institutions.
This description was generated via AI from an annual report. Updated about 1 year ago.